{"DataElement":{"publicId":"3585881","version":"1","preferredName":"Diagnostic Imaging Iobenguane Scan Type","preferredDefinition":"the type of Iobenguane (MIBG) scan performed.","longName":"3549346v1.0:3585877v1.0","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"3549346","version":"1","preferredName":"Diagnostic Imaging Iobenguane Scan","preferredDefinition":"a method that uses a visual display of a synthetic, aralkylguanidine analogue of the adrenergic neurotransmitter norepinephrine (NE) and adrenergic neuron blocking agent with potential diagnostic imaging or antineoplastic activity when radiolabeled. Iobenguane, also known as metaiodobenzylguanidine (MIBG) obtained by gathering information with a sensing device.","longName":"DX_MIBG_SCAN","context":"COG","contextVersion":"1","ObjectClass":{"publicId":"2321520","version":"1","preferredName":"Diagnostic Imaging","preferredDefinition":"Any method that uses a visual display of structural or functional patterns of organs or tissues for diagnostic evaluation..","longName":"C16502","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Diagnostic Imaging","conceptCode":"C16502","definition":"Any method that uses a visual display of structural or functional patterns of organs or tissues for diagnostic evaluation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"FD0F852B-00C3-7140-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-07-29","endDate":null,"createdBy":"PWEST","dateCreated":"2005-07-29","modifiedBy":"ONEDATA","dateModified":"2005-07-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"3553412","version":"1","preferredName":"Iobenguane Scan","preferredDefinition":"A synthetic, aralkylguanidine analogue of the adrenergic neurotransmitter norepinephrine (NE) and adrenergic neuron blocking agent with potential diagnostic imaging or antineoplastic activity when radiolabeled. Iobenguane, also known as metaiodobenzylguanidine (MIBG), localizes to adrenergic tissue and is taken up and accumulates in the granules of pre-synaptic adrenergic neurons. In radiolabeled forms, iobenguane may be used to image or eradicate neuroendocrine tissues and tumor cells.:The data or image obtained by gathering information with a sensing device.","longName":"C87757:C17999","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Iobenguane","conceptCode":"C87757","definition":"A synthetic, aralkylguanidine analogue of the adrenergic neurotransmitter norepinephrine (NE) and adrenergic neuron blocking agent with potential diagnostic imaging or antineoplastic activity when radiolabeled. Iobenguane, also known as metaiodobenzylguanidine (MIBG), is taken up and accumulates in the granules of adrenal medullary chromaffin cells and in the pre-synaptic granules of adrenergic neurons in a manner almost identical with that of NE. In radiolabeled forms, iobenguane may be used to image or eradicate neuroendocrine tissues and tumor cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Scan","conceptCode":"C17999","definition":"The data or image obtained by gathering information with a sensing device.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C6C3D255-3676-F749-E040-BB89AD432912","latestVersionIndicator":"Yes","beginDate":"2012-08-08","endDate":null,"createdBy":"WONGW","dateCreated":"2012-08-08","modifiedBy":"ONEDATA","dateModified":"2012-08-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C6A1A0F7-CB59-E1BE-E040-BB89AD434029","latestVersionIndicator":"Yes","beginDate":"2012-08-06","endDate":null,"createdBy":"WONGW","dateCreated":"2012-08-06","modifiedBy":"MAESKEB","dateModified":"2019-10-21","changeDescription":" Changed from CTEP to COG for by script Thu Jan 2 10:00:57 EST 2014","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3585877","version":"1","preferredName":"Iobenguane Scan Type","preferredDefinition":"the type of Iobenguane (MIBG) scan performed.","longName":"3585877v1.0","context":"CTEP","contextVersion":"2.31","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"15","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"I-131 MIBG","valueDescription":"Iodine I 131 Metaiodobenzylguanidine","ValueMeaning":{"publicId":"3585878","version":"1","preferredName":"Iodine I 131 Metaiodobenzylguanidine","longName":"3585878","preferredDefinition":"An I 131 radioiodinated synthetic analogue of the neurotransmitter norepinephrine. Meta-iodobenzylguanidine localizes to adrenergic tissue and, in radioiodinated forms, may be used to image or eradicate tumor cells that take up and metabolize norepinephrine.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Iobenguane I-131","conceptCode":"C970","definition":"An I 131 radioiodinated synthetic analogue of the neurotransmitter norepinephrine. Iobenguane localizes to adrenergic tissue and, in radioiodinated forms, may be used to image or eradicate tumor cells that take up and metabolize norepinephrine.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C909F7AC-3A64-EE36-E040-BB89AD435E39","latestVersionIndicator":"Yes","beginDate":"2012-09-06","endDate":null,"createdBy":"SHIDED","dateCreated":"2012-09-06","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C909F7AC-3A7D-EE36-E040-BB89AD435E39","beginDate":"2012-09-06","endDate":null,"createdBy":"SHIDED","dateCreated":"2012-09-06","modifiedBy":"ONEDATA","dateModified":"2012-09-06","deletedIndicator":"No"},{"value":"I-123 MIBG","valueDescription":"Iobenguane I-123","ValueMeaning":{"publicId":"3585880","version":"1","preferredName":"Iobenguane I-123","longName":"3585880","preferredDefinition":"An iodine (I) 123 labeled aralkylguanidine norepinephrine analogue used as a diagnostic imaging tracer. Iobenguane, structurally related to norepinephrine, functioning as a false substrate of norepinephrine, and is taken up and localized in the granules of pre-synaptic adrenergic neurons. When labeled with I-123, this agent is useful for the imaging of neuroendocrine tissues and tumors.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Iobenguane I-123","conceptCode":"C80094","definition":"An iodine (I) 123 labeled aralkylguanidine norepinephrine analogue used as a diagnostic imaging tracer. Iobenguane, structurally related to norepinephrine, functioning as a false substrate of norepinephrine, and is taken up and localized in the granules of pre-synaptic adrenergic neurons. When labeled with I-123, this agent is useful for the imaging of neuroendocrine tissues and tumors.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C909F7AC-3A8A-EE36-E040-BB89AD435E39","latestVersionIndicator":"Yes","beginDate":"2012-09-06","endDate":null,"createdBy":"SHIDED","dateCreated":"2012-09-06","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C909F7AC-3AA3-EE36-E040-BB89AD435E39","beginDate":"2012-09-06","endDate":null,"createdBy":"SHIDED","dateCreated":"2012-09-06","modifiedBy":"ONEDATA","dateModified":"2012-09-06","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2234813","version":"1","preferredName":"Type","preferredDefinition":"Type; a subdivision of a particular kind of thing.","longName":"C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F970CDF6-F90E-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C909F7AC-3A4E-EE36-E040-BB89AD435E39","latestVersionIndicator":"Yes","beginDate":"2012-09-06","endDate":null,"createdBy":"SHIDED","dateCreated":"2012-09-06","modifiedBy":"WONGW","dateModified":"2013-11-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[{"name":"MIBGScanTp","type":"COG GDE Short Name","context":"CTEP"},{"name":"COG","type":"USED_BY","context":"COG"}],"ReferenceDocuments":[{"name":"MIBG Scan Type","type":"Preferred Question Text","description":"MIBG Scan Type","url":null,"context":"CTEP"},{"name":"COG CRF Text 1","type":"Alternate Question Text","description":"MIBG scan type:","url":null,"context":"COG"}],"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C909F7AC-3AAD-EE36-E040-BB89AD435E39","latestVersionIndicator":"Yes","beginDate":"2012-09-06","endDate":null,"createdBy":"SHIDED","dateCreated":"2012-09-06","modifiedBy":"CHANGP","dateModified":"2017-03-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}